Abstract
The technology for production of murine monoclonal antibodies has advanced enormously since its introduction by Köhler and Milstein (1975). However, the production of human monoclonal antibodies by fusion technologies has been hampered, mainly by the current scarcity of suitable human cell lines as fusion partners. Hypoxanthine-aminopterin-thymidine (HAT)-sensitive murine plasmacytomas have been fused with human lymphocytes to yield mouse-human hybrids that secrete human antibody against the Forssman antigen (Nowinski et al., 1980), keyhole limpet hemocyanin (KLH) (Lane et al., 1982), tetanus toxoid (Kozbor et al.,1982b; Butler et al., 1983), human tumor-associated antigen (Schlom et al.,1980; Sikora and Wright, 1981; Sikora and Phillips, 1981), and multiple endocrine organs (Satoh et al., 1983). These interspecies hybridomas preferentially segregate human chromosomes, making it difficult to derive stable lines secreting human antibody. However, the loss of human chromosomes from mouse-human hybridomas is not random. It is known, for example, that human chromosomes 14 (heavy chain) and 22 (λ light chain) are preferentially retained, whereas chromosome 2 (κ chain) is preferentially lost (Croce et al.,1979; Erikson et al., 1981).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abrams, P. G., Knost, J. A., Clarke, G., Wilburn, S., Oldham, R. K., and Foon, K. A., 1983, Determination of the optimal human cell lines for development of human hybridomas, J. Immunol. 131: 1201–1204.
Atlaw, T., Kozbor, D., and Roder, J. C., 1984, Human monoclonal antibodies against Mycobacterium leprae, Inf. Immun.
Bengtsson, D. B., Nabholz, M., Kennett, R. H., and Bodmer, W. F., 1975, Human intraspecific somatic cell hybrids: A genetic and karyotypic analysis of crosses between lymphocytes and D98/AH-2, Somat. Cell Genet. 1: 41–64.
Ber, R., Klein, G., Moar, M., Povey, S., Rosén, A., Westman, A., Yefenof, E., and Zeuthen, J., 1978, Somatic cell hybrids between human lymphoma lines. IV. Establishment and characterization of a P3HR-1/Daudi hybrid, Int. J. Cancer 21: 707.
Butler, Y. L., Lane, H. C., and Fauci, A. S., 1983, Delineation of optimal conditions for producing mouse—human heterohybridomas from human peripheral blood B cells of immunized subjects, J. Immunol. 130: 165–168.
Chiorazzi, N., Wasserman, R. J., and Kunkel, H. G., 1982, Use of Epstein—Barr virus-transformed B cell lines for the generation of immunoglobulin-producing human B cell hybridomas, J. Exp. Med. 156: 930–935.
Croce, C. M., Shander, M., Martinis, J., Cicurel, L., D’Ancona, G. G., Dolby, T. W., and Koprowski, H., 1979, Chromosomal locations of the genes for human immunoglobulin heavy chains, Eur. J. Immunol. 10: 486–488.
Croce, C. M., Linnenbach, A., Hall, W., Steplewski, Z., and Koprowski, H., 1980, Production of human hybridomas secreting antibodies to measles virus, Nature 228: 488–489.
Diehl, V., Schaadt, M., Kirchner, H., Hellriegel, K. P., Gudat, F., Fonatsch, C., Lskewitz, E., and Guggenheim, R., 1978, Long-term cultivation of plasma cell leukemia cells and autologous lymphoblasts (LCL) in vitro: A comparative study, Blut 36: 331–338.
Dwyer, D. S., Bradley, R. J., Urguhart, C. K., and Kearney, J. F., 1983, Naturally occurring antiidiotypic antibodies in myasthenia gravis patients, Nature 301: 611–614.
Edwards, P. A., Smith, C. M., Neville, A. M., and O’Hare, M. J., 1982, A human-hybridoma system based on a fast-growing mutant of the ARH-77 plasma cell leukemia-derived line, Eur. J. Immunol. 12: 641–648.
Eisenbarth, G. S., Linnenbach, A., Jackson, R., Scearce, R., and Croce, C. M., 1982, Human hybridomas secreting anti-islet autoantibodies, Nature 300: 264–267.
Erikson, J., Martinis, J., and Croce, C. M., 1981, Assignment of the genes for human k immunoglobulin chains to chromosome 22, Nature 294: 173–175.
Glassy, M. C., Handley, H. H., Hagiwara, H., and Royston, I., 1983, UC 729–6, a human lymphoblastoid B-cell line useful for generating antibody-secreting human—human hybridomas, Proc. Natl. Acad. Sci. USA 80: 6327–6331.
Ishihara, N., Kiyofuzi, T., and Oboshi, S., 1977, Establishment and characterization of a human plasmacyte cell line derived from a patient with IgD multiple myeloma, in: Proceedings Japanese Cancer Association, Annual Meeting, 36: 120–126.
Jobin, M. E., Fahey, J. L., and Price, Z., 1974, Long-term establishment of a human plasmacyte cell line derived from a patient with IgD multiple myeloma. I. Requirement of a plasmacytestimulating factor for the proliferation of myeloma cells in tissue culture, J. Exp. Med. 140: 494–507.
Karpas, A., Fischer, P., and Swirsky, D., 1982, Human plasmacytoma with an unusual karyotype
growing in vitro and producing light-chain immunoglobulin, Lancet 1:931–933.
Kearney, J. F., Radbrusch, A., Liesegang, B., and Rajewski, K., 1979, A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibodysecreting hybrid cell lines, J. Immunol. 1231: 1548–1550.
Köhler, G., and Milstein, C., 1975, Continuous cultures of fused cells secreting antibody of predefined specificity, Nature 256: 495–497.
Köhler, G., Howe, S. C., and Milstein, C., 1976, Fusion between immunoglobulin-secreting and non-secreting myeloma cell lines, Eur. J. Immunol. 6: 292–295.
Kozbor, D., and Roder, J. C., 1981, Requirements for the establishment of high-titered human monoclonal antibodies against tetanus toxoid using the Epstein—Barr virus technique, J. Immunol. 127: 1275–1280.
Kozbor, D., and Roder, J. C., 1983, Monoclonal antibodies produced by human lymphocytes, Immunol. Today 4 (3): 72–79.
Kozbor, D., and Roder, J. C., 1984, In vitro stimulated lymphocytes as a source of human hybridomas, Eur. J. Immunol. 14: 23–27.
Kozbor, D., Lagarde, A. E., and Roder, J. C., 1982a, Human hybridomas constructed with antigen-specific Epstein—Barr virus-transformed cell lines, Proc. Natl. Acad. Sci. USA 79: 6651–6655.
Kozbor, D., Roder, J. C., Chang, T. H., Steplewski, Z., and Koprowski, H., 1982b, Human anti-tetanus toxoid monoclonal antibody secreted by EBV-transformed human B cells fused with the murine myeloma, Hybridoma 1 (3): 323–328.
Kozbor, D., Dexter, D., and Roder, J. C., 1983, A comparative analysis of the phenotypic characteristics of available fusion partners for the construction of human hybridomas, Hybridoma 2 (1): 7–16.
Kozbor, D., Tripputi, P., Roder, J. C., and Croce, C. M., 1984, A human hybrid myeloma for production of human monoclonal antibody, J. Immunol., 133: 3001–3005.
Lane, H. C., Shelhamer, J. H., Motowski, H. S., and Fauci, A. S., 1982, Human monoclonal anti-keyhole limpet hemocyanin antibody-secreting hybridoma produced from peripheral blood B lymphocytes of a keyhole limpet hemocyanin-immune individual, J. Exp. Med. 155: 333–337.
Larrick, J. W., Truitt, K. E., Raubitschek, A. A., Senyk, G., and Wang, J. C. N., 1983, Characterization of human hybridomas secreting antibody to tetanus toxoid, Proc. Natl. Acad. Sci. USA 80: 6376–6380.
Matsuoka, Y., Moore, G. E., Yagi, Y., and Pressman, D., 1967, Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma, Proc. Soc. Exp. Biol. 125: 1246–1250.
Nilsson, K., 1978, Established human lymphoid cell lines as model for B-lymphocyte differentiation, in: Human Lymphocyte Differentiation: Its Application to Cancer ( B. Serrou and C. Rosenfeld, eds.), Elsevier/North-Holland, Amsterdam, pp. 307–317.
Nilsson, K., and Pontén, J., 1975, Classification and biological nature of established human hematopoietic cell lines, Int. J. Cancer 15: 321–341.
Nilsson, K., Bennich, H., Johansson, S. G. O., and Pontén, J., 1970, Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient, Clin. Exp. Immunol. 7: 477–489.
Nowinski, R., Berglund, C., Lane, Y., Lostrom, M., Bernstein, I., Young, W., Hakomori, S., Hill, L., and Cooney, M., 1980, Human monoclonal antibody against Forssman antigen, Science 210: 537–539.
Olsson, L., and Kaplan, H. S., 1980, Human—human hybridomas producing monoclonal antibodies of predefined antigenic specificity, Proc. Natl. Acad. Sci. USA 77: 5429–5431.
Olsson, L., Kronstrom, H., Cambon-De Mouzom, A., Honsik, C., Brodin, T., and Jakobsen, B., 1983, Antibody-producing human—human hybridoma. I. Technical aspects, J. Immunol. Meth. 61: 17–32.
Olsson, L., Andreasen, R. B., Ost, A., Christensen, B., and Biberfeld, P., 1984, Antibody-producing human—human hybridomas. II. Derivation and characterization of an antibody specific for human leukemia cells, J. Exp. Med. 159: 537–550.
Osband, M., Cavagnaw, J., and Kupchick, H. Z., 1981, Biochemical analysis of specific histamine HI and H2 receptors on lymphocytes, Blood 60 (5, Suppl. 1): 81a (abstract).
Phillips, J., Sikora, K., and Watson, J. V., 1982, Localization of glioma by human monoclonal antibody, Lancet 2: 1214–1215.
Pickering, J. W., and Gelder, F. B., 1982, A human myeloma cell line that does not express immunoglobulin but yields a high frequency of antibody-secreting hybridomas, J. Immunol. 129: 406–412.
Ritts, R. E., Jr., Ruiz-Arguelles, A., Weyl, K. G., Bradley, A. L., Weihmeir, B., Jacobsen, D. Y., and Strehlo, B. L., 1983, Establishment and characterization of a human non-secretory
plasmoid cell line and its hybridization with human B cells, Int. J. Cancer 31: 133–141.
Satoh, J., Prabhakar, B. S., Haspel, M. V., Ginsberg-Fellner, F., and Notkins, A. L., 1983, Human monoclonal auto-antibodies that react with multiple endocrine organs, N. Engl. J. Med. 309: 217–220.
Schlom, T., Wunderlich, D., and Teramoto, Y. A., 1980, Generation of human monoclonal antibodies reactive with human mammary carcinoma cells, Proc. Natl. Acad. Sci. USA 77: 6841–6845.
Shibuya, T., Niho, Y., Yamasaki, K., Nakayama, K., Oka, Y., Arase, K., and Yanase, T., 1980, Establishment of a lambda immunoglobulin producing myeloma cell line, Acta Haem. Jpn. 43: 256 (In Japanese).
Shoenfeld, Y., Hsu-Lin, S. C., Gabriels, J. E., Silberstein, L, E., Furie, B. C., Furie, B., Stollar, B. D., and Schwartz, R. S., 1982, Production of auto-antibodies by human—human hybridomas, J. Clin. Invest. 70: 205–208.
Shoenfeld, Y., Rauch, J., Massicotte, H., Datta, S. K., Andre-Schwartz, J., Stollar, B. D., and Schwartz, R. S., 1983, Polyspecificity of monoclonal lupus auto-antibodies produced by human—human hybridomas, N. Engl. J. Med. 308: 414–420.
Sikora, K., and Phillips, J., 1981, Human monoclonal antibodies to glioma cells, Br. J. Cancer 43: 105–107.
Sikora, K., and Wright, R., 1981, Human monoclonal antibodies to lung-cancer antigens, Br. J. Cancer 43: 696–700.
Sikora, K., Alderson, T., Phillips, J., and Watson, J. V., 1982, Human hybridomas from malignant gliomas, Lancet 1: 11–14.
Stähli, Ch., Staehelin, T., Miggiano, V., Schmidt, J., and Häring, P., 1980, High frequencies of antigen-specific hybridomas: Dependence on immunization parameters and prediction by spleen cell analysis, J. Immunol. Meth. 32: 297–304.
Standbridge, E. J., Der, C. J., Roenson, C. J., Nishimi, R. Y., Peehl, D. M., Weissman, B. E., and Wilkinson, J. E., 1982, Human cell hybrids: Analysis of transformation and tumorigenicity, Science 215: 252–259.
Strike, L., Devens, B. H., and Lundak, R. L., 1982, Production of human hybridomas secreting specific immunoglobulin following in vitro immunization, Immunology 163 (2–4): 272 (abstract).
Teng, N. N. H., Lam, K. S., Riera, F. C., and Kaplan, H., 1983, Construction and testing of mouse—human heteromyelomas for human monoclonal antibody production, Proc. Natl. Acad. Sci. USA 80: 7308–7312.
Togawa, A., Inoue, N., Miyamoto, K., Hyodo, H., and Namba, M., 1982, Establishment and characterization of a human myeloma cell line (KMM-1), Int. J. Cancer 29: 495–500.
Warenius, H. M., Taylor, J. W., Durack, B. E., and Cross, P. A., 1983, The production of human hybridomas from patients with malignant melanoma. The effect of pre-stimulation of lymphocytes with pokeweed mitogen, Eur. J. Cancer Clin. Oncol. 19: 347–355.
Zeijlemaker, W. P., Astaldi, G. C. B., Janssen, M. C., Stricker, E. A. M., and Tiebout, R. F., 1982, Production of human monoclonal antibodies, in: Proceedings 15th International Leucocyte Culture Conference, Asilomar, pp. 368–369.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Plenum Press, New York
About this chapter
Cite this chapter
Kozbor, D., Croce, C.M. (1985). Fusion Partners for Production of Human Monoclonal Antibodies. In: Engleman, E.G., Foung, S.K.H., Larrick, J.W., Raubitschek, A.A. (eds) Human Hybridomas and Monoclonal Antibodies. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4949-5_2
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4949-5_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4951-8
Online ISBN: 978-1-4684-4949-5
eBook Packages: Springer Book Archive